I see what you mean. And I still find "capitalize on pain" too broad a framing for what the app. Characterizing it that way does not inform and draws parallels

I see what you mean. And I still find "capitalize on pain" too broad a framing for what the app. Characterizing it that way does not inform and draws parallels to other, less ethical players that "capitalize on pain". Such as Purdue Pharma for example.